Johasen, M., Perera, R., Abenojar, E., Wang, X., Vincent, J., Exner, A., & Brady-Kalnay, S.(2021).Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.Int. J. Mol. Sci.,22(4),1983.
Wang, X., Shirke, A., Walker, E., Sun, R., Ramamurthy, G., Wang, J., Shan, L., Mangadlao, J., Dong, Z., Wang, Z., Liu, H., Schluchter, M., Luo, D., Wang, Y., Stauffer, S., Brady-Kalnay, S., Hoimes, C., Lee, Z., & Basilion, J.(2021).Small-Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer..Cancers,13(3),417.
Covarrubias, G., Johansen, M., Vincent, J., Erokwu, B., Craig, S., Rahmy, A., Cha, A., Lorkowski, M., MacAskill, C., Scott, B., Gargesha, M., Roy, D., Flask, C., Karathanasis, E., & Brady-Kalnay, S.(2020).PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.Nanomedicine: Nanotechnology, Biology, and Medicine,28
Gu, Y., Wang, C., Anderson, C., Liu, Y., Zhu, C., Johansen, M., Ma, D., Jiang, Y., Ramos-Estebanez, C., Brady-Kalnay, S., Griswold, M., Flask, C., & Yu, X.(2018).Fast magnetic resonance fingerprinting for dynamic contrast-enhanced studies in mice: Gu et al..Magnetic Resonance in Medicine,80(6),2681-2690.
Johansen, M., Gao, Y., Hutnick, M., Craig, S., Pokorski, J. K., Flask, C. K., & Brady-Kalnay, S. K.(2017).Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.Analytical Chemistry,89(11),5932-5939.
Anderson, C., Donnola, S., Jiang, Y., Batesole, J., Darrah, R., Drumm, M., Brady-Kalnay, S., Steinmetz, N., Yu, X., Griswold, M., & Flask, C.(2017).Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents.Scientific Reports,7(1).
